

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 9.97016601 |
| 2 | * angiotensin maturation (GO:0002003) | 8.53937647 |
| 3 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.79060694 |
| 4 | adhesion of symbiont to host cell (GO:0044650) | 5.75702377 |
| 5 | virion attachment to host cell (GO:0019062) | 5.75702377 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.72736948 |
| 7 | vitamin A metabolic process (GO:0006776) | 5.61285875 |
| 8 | phospholipid efflux (GO:0033700) | 5.27197679 |
| 9 | flavonoid metabolic process (GO:0009812) | 5.11476053 |
| 10 | plasma lipoprotein particle assembly (GO:0034377) | 5.07325618 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 5.05556314 |
| 12 | hormone catabolic process (GO:0042447) | 5.05414142 |
| 13 | adhesion of symbiont to host (GO:0044406) | 4.94046213 |
| 14 | lipoprotein metabolic process (GO:0042157) | 4.89868283 |
| 15 | drug catabolic process (GO:0042737) | 4.89238722 |
| 16 | protein-lipid complex assembly (GO:0065005) | 4.86442476 |
| 17 | cholesterol efflux (GO:0033344) | 4.85140311 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 4.75845594 |
| 19 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.73851428 |
| 20 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.73851428 |
| 21 | lipoprotein transport (GO:0042953) | 4.64410344 |
| 22 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.61081198 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.47169318 |
| 24 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.47150316 |
| 25 | modified amino acid transport (GO:0072337) | 4.37292151 |
| 26 | digestive system process (GO:0022600) | 4.23705612 |
| 27 | sterol transport (GO:0015918) | 4.17688853 |
| 28 | cholesterol transport (GO:0030301) | 4.17688853 |
| 29 | cholesterol homeostasis (GO:0042632) | 4.13427373 |
| 30 | peptide catabolic process (GO:0043171) | 4.11124702 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 4.10965746 |
| 32 | glycosphingolipid catabolic process (GO:0046479) | 4.10640960 |
| 33 | glucose 6-phosphate metabolic process (GO:0051156) | 4.10533632 |
| 34 | sterol homeostasis (GO:0055092) | 4.10019428 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.06622297 |
| 36 | actin filament depolymerization (GO:0030042) | 4.05138459 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.02551036 |
| 38 | negative regulation of cholesterol transport (GO:0032375) | 4.02551036 |
| 39 | glycolipid catabolic process (GO:0019377) | 3.98996611 |
| 40 | epoxygenase P450 pathway (GO:0019373) | 3.93982179 |
| 41 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.90157381 |
| 42 | NADH metabolic process (GO:0006734) | 3.83145585 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 3.82843257 |
| 44 | bile acid and bile salt transport (GO:0015721) | 3.82592495 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.81967238 |
| 46 | regulation of guanylate cyclase activity (GO:0031282) | 3.79519957 |
| 47 | digestion (GO:0007586) | 3.78181375 |
| 48 | regulation of cellular extravasation (GO:0002691) | 3.75110582 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.66550811 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.66550811 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66550811 |
| 52 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.64733967 |
| 53 | fructose metabolic process (GO:0006000) | 3.63516674 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 3.52953584 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.49359534 |
| 56 | plasma lipoprotein particle organization (GO:0071827) | 3.45962909 |
| 57 | protein-lipid complex subunit organization (GO:0071825) | 3.44247711 |
| 58 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.43068986 |
| 59 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.43068986 |
| 60 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.40956117 |
| 61 | response to hepatocyte growth factor (GO:0035728) | 3.40956117 |
| 62 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.36789023 |
| 63 | diacylglycerol metabolic process (GO:0046339) | 3.35856928 |
| 64 | ceramide catabolic process (GO:0046514) | 3.28259743 |
| 65 | phospholipid homeostasis (GO:0055091) | 3.26420670 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25903219 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.24504659 |
| 68 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21089286 |
| 69 | urea cycle (GO:0000050) | 3.19573821 |
| 70 | urea metabolic process (GO:0019627) | 3.19573821 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.17585052 |
| 72 | * peptide hormone processing (GO:0016486) | 3.15435068 |
| 73 | sphingomyelin metabolic process (GO:0006684) | 3.11645449 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11439124 |
| 75 | drinking behavior (GO:0042756) | 3.11067116 |
| 76 | membrane lipid catabolic process (GO:0046466) | 3.09808885 |
| 77 | sphingolipid catabolic process (GO:0030149) | 3.08748967 |
| 78 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.07266326 |
| 79 | positive regulation of p38MAPK cascade (GO:1900745) | 3.06559536 |
| 80 | transepithelial transport (GO:0070633) | 3.04428187 |
| 81 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.99802318 |
| 82 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.99802318 |
| 83 | endocrine process (GO:0050886) | 2.99802318 |
| 84 | nucleobase catabolic process (GO:0046113) | 2.99751237 |
| 85 | phenylpropanoid metabolic process (GO:0009698) | 2.98038539 |
| 86 | lipid homeostasis (GO:0055088) | 2.97091056 |
| 87 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97016031 |
| 88 | negative regulation of digestive system process (GO:0060457) | 2.96618001 |
| 89 | drug metabolic process (GO:0017144) | 2.96616273 |
| 90 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.96184963 |
| 91 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.95288303 |
| 92 | oligosaccharide catabolic process (GO:0009313) | 2.95215905 |
| 93 | homocysteine metabolic process (GO:0050667) | 2.94116470 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.93928174 |
| 95 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.93162669 |
| 96 | regulation of systemic arterial blood pressure (GO:0003073) | 2.92179249 |
| 97 | regulation of cholesterol transport (GO:0032374) | 2.91656357 |
| 98 | regulation of sterol transport (GO:0032371) | 2.91656357 |
| 99 | acylglycerol homeostasis (GO:0055090) | 2.90913440 |
| 100 | triglyceride homeostasis (GO:0070328) | 2.90913440 |
| 101 | drug transport (GO:0015893) | 2.89996200 |
| 102 | sulfur compound transport (GO:0072348) | 2.88879466 |
| 103 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.85436960 |
| 104 | nitrogen cycle metabolic process (GO:0071941) | 2.82781341 |
| 105 | transcytosis (GO:0045056) | 2.82497726 |
| 106 | regulation of extracellular matrix disassembly (GO:0010715) | 2.79821260 |
| 107 | sulfate transmembrane transport (GO:1902358) | 2.78126094 |
| 108 | cyclooxygenase pathway (GO:0019371) | 2.72930916 |
| 109 | cysteine metabolic process (GO:0006534) | 2.72410559 |
| 110 | exogenous drug catabolic process (GO:0042738) | 2.72342593 |
| 111 | positive regulation of pseudopodium assembly (GO:0031274) | 2.70983440 |
| 112 | regulation of cholesterol storage (GO:0010885) | 2.70820638 |
| 113 | alpha-linolenic acid metabolic process (GO:0036109) | 2.70659054 |
| 114 | drug transmembrane transport (GO:0006855) | 2.70075097 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.69205188 |
| 116 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.68536446 |
| 117 | immunoglobulin mediated immune response (GO:0016064) | 2.67538446 |
| 118 | regulation of mononuclear cell migration (GO:0071675) | 2.67119947 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.65828139 |
| 120 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.65344854 |
| 121 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.64854287 |
| 122 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64709184 |
| 123 | modulation by symbiont of host defense response (GO:0052031) | 2.64709184 |
| 124 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64709184 |
| 125 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64709184 |
| 126 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64709184 |
| 127 | modulation by symbiont of host immune response (GO:0052553) | 2.64709184 |
| 128 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64362853 |
| 129 | response to peptidoglycan (GO:0032494) | 2.64195445 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63515857 |
| 131 | response to hydroperoxide (GO:0033194) | 2.61142531 |
| 132 | renal system process involved in regulation of blood volume (GO:0001977) | 2.59854674 |
| 133 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.59199962 |
| 134 | cellular carbohydrate catabolic process (GO:0044275) | 2.58591581 |
| 135 | thyroid hormone metabolic process (GO:0042403) | 2.57967621 |
| 136 | eosinophil chemotaxis (GO:0048245) | 2.55546510 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.54914325 |
| 138 | leukotriene metabolic process (GO:0006691) | 2.54033413 |
| 139 | detection of other organism (GO:0098543) | 2.52763912 |
| 140 | negative regulation of cell killing (GO:0031342) | 2.49182096 |
| 141 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.49182096 |
| 142 | detection of bacterium (GO:0016045) | 2.47859769 |
| 143 | cellular response to cadmium ion (GO:0071276) | 2.46509239 |
| 144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45774543 |
| 145 | barbed-end actin filament capping (GO:0051016) | 2.44421462 |
| 146 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.43901602 |
| 147 | T-helper 1 type immune response (GO:0042088) | 2.42536000 |
| 148 | low-density lipoprotein particle remodeling (GO:0034374) | 2.41332475 |
| 149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.39930859 |
| 150 | regulation of chemokine biosynthetic process (GO:0045073) | 2.39186573 |
| 151 | arachidonic acid metabolic process (GO:0019369) | 2.38819994 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.37330360 |
| 153 | regulation of antigen processing and presentation (GO:0002577) | 2.37131252 |
| 154 | regulation of pseudopodium assembly (GO:0031272) | 2.36154511 |
| 155 | cellular glucuronidation (GO:0052695) | 2.31835461 |
| 156 | regulation of podosome assembly (GO:0071801) | 2.30603898 |
| 157 | intestinal cholesterol absorption (GO:0030299) | 10.7656242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.28960839 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.00930373 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.86672991 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.84164081 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.80299794 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57195322 |
| 7 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.66686313 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58976693 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57552897 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56287449 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.44083568 |
| 12 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.34777693 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.28510986 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.17363935 |
| 15 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16356628 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15673086 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.13489279 |
| 18 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.08936464 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.05485164 |
| 20 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.01510912 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98913735 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.96601229 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92591267 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84816023 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77540035 |
| 26 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.76172984 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.75493706 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73799376 |
| 29 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72322529 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70527932 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69269885 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67429545 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64894449 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61222922 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58454865 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54819406 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54376255 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52674787 |
| 39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48287992 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47814045 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43735460 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43317210 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41990937 |
| 44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41860957 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38589010 |
| 46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37795120 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36453865 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36315063 |
| 49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35809391 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35367939 |
| 51 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35166566 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34964759 |
| 53 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33068531 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32705144 |
| 55 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.31095002 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29255396 |
| 57 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28682885 |
| 58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27060319 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23537917 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.22375221 |
| 61 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22169348 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21031241 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19710883 |
| 64 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19275355 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19123029 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18554386 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15827358 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15682008 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15462748 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.15128930 |
| 71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13009620 |
| 72 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12298525 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11331688 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10871601 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10730264 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10647994 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10543198 |
| 78 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10423599 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10137935 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09999138 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08546717 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07950528 |
| 83 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06930131 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05235526 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04629828 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04234148 |
| 87 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.03384370 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02891078 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02761269 |
| 90 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02551841 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01718418 |
| 92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01090452 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00678990 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99715582 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99617441 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99474945 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99379872 |
| 98 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97817224 |
| 99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97326276 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97147016 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 0.96962883 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96328368 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94150044 |
| 104 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92905122 |
| 105 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92881838 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92461147 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91723416 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90988230 |
| 109 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.90936057 |
| 110 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90475330 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89993298 |
| 112 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87993757 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87058737 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86879133 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85768568 |
| 116 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85643575 |
| 117 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85592289 |
| 118 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83889425 |
| 119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83620154 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83158379 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82453594 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81782290 |
| 123 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80440727 |
| 124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80292765 |
| 125 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.79879888 |
| 126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79154035 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78604058 |
| 128 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78577369 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77537670 |
| 130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77429779 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76846697 |
| 132 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74443438 |
| 133 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74443438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.25108708 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.34609229 |
| 3 | MP0009840_abnormal_foam_cell | 4.57032802 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 4.39596602 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.70387662 |
| 6 | MP0003183_abnormal_peptide_metabolism | 3.58788052 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46077112 |
| 8 | MP0003252_abnormal_bile_duct | 3.06492125 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.02623047 |
| 10 | MP0005365_abnormal_bile_salt | 2.92319792 |
| 11 | MP0004264_abnormal_extraembryonic_tissu | 2.84134160 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.77794521 |
| 13 | MP0002254_reproductive_system_inflammat | 2.28426859 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.26892367 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.26337745 |
| 16 | MP0003724_increased_susceptibility_to | 2.22377310 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.17479696 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.84684296 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.81313364 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.78462770 |
| 21 | MP0000462_abnormal_digestive_system | 1.68225288 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.66278692 |
| 23 | MP0003866_abnormal_defecation | 1.65257394 |
| 24 | MP0001790_abnormal_immune_system | 1.61443049 |
| 25 | MP0005387_immune_system_phenotype | 1.61443049 |
| 26 | MP0005332_abnormal_amino_acid | 1.52899145 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.49300179 |
| 28 | MP0000609_abnormal_liver_physiology | 1.43885189 |
| 29 | MP0002998_abnormal_bone_remodeling | 1.42534421 |
| 30 | MP0004510_myositis | 1.40637820 |
| 31 | MP0000538_abnormal_urinary_bladder | 1.40424937 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.39183162 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.36690734 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.36625726 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.34832432 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.34403044 |
| 37 | MP0000685_abnormal_immune_system | 1.32613824 |
| 38 | MP0000604_amyloidosis | 1.30338087 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.30102569 |
| 40 | MP0005448_abnormal_energy_balance | 1.30037244 |
| 41 | MP0004947_skin_inflammation | 1.29813216 |
| 42 | MP0005409_darkened_coat_color | 1.29364761 |
| 43 | MP0006082_CNS_inflammation | 1.26256229 |
| 44 | MP0004147_increased_porphyrin_level | 1.24322511 |
| 45 | MP0005671_abnormal_response_to | 1.23025834 |
| 46 | MP0008004_abnormal_stomach_pH | 1.22426767 |
| 47 | MP0003448_altered_tumor_morphology | 1.22008349 |
| 48 | MP0009379_abnormal_foot_pigmentation | 1.21333635 |
| 49 | MP0005083_abnormal_biliary_tract | 1.20569264 |
| 50 | MP0003436_decreased_susceptibility_to | 1.18378574 |
| 51 | MP0000343_altered_response_to | 1.18367162 |
| 52 | MP0000858_altered_metastatic_potential | 1.15261410 |
| 53 | MP0002723_abnormal_immune_serum | 1.14819595 |
| 54 | MP0001800_abnormal_humoral_immune | 1.14587384 |
| 55 | * MP0002452_abnormal_antigen_presenting | 1.14334676 |
| 56 | MP0008260_abnormal_autophagy | 1.11241682 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.10225057 |
| 58 | MP0002796_impaired_skin_barrier | 1.09175354 |
| 59 | MP0003279_aneurysm | 1.07504175 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.06471216 |
| 61 | MP0001663_abnormal_digestive_system | 1.05490435 |
| 62 | MP0003091_abnormal_cell_migration | 1.05268370 |
| 63 | MP0005381_digestive/alimentary_phenotyp | 1.03547545 |
| 64 | MP0001958_emphysema | 1.03495615 |
| 65 | MP0001664_abnormal_digestion | 1.02138129 |
| 66 | MP0002822_catalepsy | 1.01469441 |
| 67 | MP0000477_abnormal_intestine_morphology | 0.98745287 |
| 68 | MP0001849_ear_inflammation | 0.98417196 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 0.98142414 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.97686991 |
| 71 | MP0003878_abnormal_ear_physiology | 0.97686991 |
| 72 | MP0003329_amyloid_beta_deposits | 0.97558805 |
| 73 | * MP0001819_abnormal_immune_cell | 0.96750860 |
| 74 | MP0005164_abnormal_response_to | 0.96123263 |
| 75 | * MP0002420_abnormal_adaptive_immunity | 0.95084629 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.94786757 |
| 77 | MP0001873_stomach_inflammation | 0.94688471 |
| 78 | MP0005464_abnormal_platelet_physiology | 0.91814708 |
| 79 | MP0004043_abnormal_pH_regulation | 0.91772724 |
| 80 | MP0005166_decreased_susceptibility_to | 0.90839997 |
| 81 | MP0006054_spinal_hemorrhage | 0.89166814 |
| 82 | MP0009764_decreased_sensitivity_to | 0.88085413 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.87967017 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.87036302 |
| 85 | MP0003303_peritoneal_inflammation | 0.85634754 |
| 86 | MP0009278_abnormal_bone_marrow | 0.84740150 |
| 87 | MP0008469_abnormal_protein_level | 0.84544056 |
| 88 | MP0003879_abnormal_hair_cell | 0.83665250 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83474877 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.81846196 |
| 91 | MP0005310_abnormal_salivary_gland | 0.81183298 |
| 92 | MP0005390_skeleton_phenotype | 0.79439349 |
| 93 | MP0000537_abnormal_urethra_morphology | 0.79116447 |
| 94 | MP0002405_respiratory_system_inflammati | 0.78751672 |
| 95 | MP0000490_abnormal_crypts_of | 0.75771248 |
| 96 | MP0003828_pulmonary_edema | 0.74947382 |
| 97 | MP0001533_abnormal_skeleton_physiology | 0.74668471 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.74512073 |
| 99 | MP0009697_abnormal_copulation | 0.72676677 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.71811417 |
| 101 | MP0005451_abnormal_body_composition | 0.71321366 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.70477989 |
| 103 | MP0001881_abnormal_mammary_gland | 0.70255870 |
| 104 | MP0005257_abnormal_intraocular_pressure | 0.69230910 |
| 105 | MP0005025_abnormal_response_to | 0.69118601 |
| 106 | MP0000598_abnormal_liver_morphology | 0.68896928 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.68820026 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.68071652 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.67833454 |
| 110 | MP0001764_abnormal_homeostasis | 0.67752939 |
| 111 | MP0003868_abnormal_feces_composition | 0.67575702 |
| 112 | MP0010678_abnormal_skin_adnexa | 0.67074778 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.66433770 |
| 114 | MP0005023_abnormal_wound_healing | 0.64918870 |
| 115 | MP0009785_altered_susceptibility_to | 0.64768012 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.64200006 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.63574330 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.61137791 |
| 119 | MP0009115_abnormal_fat_cell | 0.61053533 |
| 120 | * MP0002419_abnormal_innate_immunity | 0.60707828 |
| 121 | MP0001756_abnormal_urination | 0.59594269 |
| 122 | MP0002876_abnormal_thyroid_physiology | 0.56285624 |
| 123 | MP0009053_abnormal_anal_canal | 0.55639258 |
| 124 | MP0004858_abnormal_nervous_system | 0.54770761 |
| 125 | MP0000249_abnormal_blood_vessel | 0.54530949 |
| 126 | MP0005501_abnormal_skin_physiology | 0.54406818 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.53259077 |
| 128 | MP0003075_altered_response_to | 0.53157411 |
| 129 | MP0002138_abnormal_hepatobiliary_system | 0.52772819 |
| 130 | MP0005367_renal/urinary_system_phenotyp | 0.52729716 |
| 131 | MP0000516_abnormal_urinary_system | 0.52729716 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.52721855 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.52055658 |
| 134 | MP0010307_abnormal_tumor_latency | 0.51465661 |
| 135 | MP0005266_abnormal_metabolism | 0.51424209 |
| 136 | MP0003172_abnormal_lysosome_physiology | 0.51148678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.88272922 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.43618562 |
| 3 | Ileus (HP:0002595) | 5.66998031 |
| 4 | Acanthocytosis (HP:0001927) | 5.52765418 |
| 5 | Abnormality of proline metabolism (HP:0010907) | 5.39139321 |
| 6 | Hydroxyprolinuria (HP:0003080) | 5.39139321 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 5.18399926 |
| 8 | Malnutrition (HP:0004395) | 4.68346368 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 4.58890198 |
| 10 | Fat malabsorption (HP:0002630) | 4.44815341 |
| 11 | Xanthomatosis (HP:0000991) | 4.27160412 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.19351939 |
| 13 | Hyperglycinuria (HP:0003108) | 3.75638586 |
| 14 | Right ventricular cardiomyopathy (HP:0011663) | 3.72503563 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.63552706 |
| 16 | Hypercholesterolemia (HP:0003124) | 3.57286210 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55281897 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55281897 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55281897 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.54439303 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.53004891 |
| 22 | Pigmentary retinal degeneration (HP:0001146) | 3.49233366 |
| 23 | Epidermoid cyst (HP:0200040) | 3.31128466 |
| 24 | Poikilocytosis (HP:0004447) | 3.30813405 |
| 25 | Cupped ribs (HP:0000887) | 3.27954650 |
| 26 | Widely patent fontanelles and sutures (HP:0004492) | 3.17004075 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.02799833 |
| 28 | Abnormality of complement system (HP:0005339) | 3.02104321 |
| 29 | Potter facies (HP:0002009) | 2.98668431 |
| 30 | Facial shape deformation (HP:0011334) | 2.98668431 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.96453608 |
| 32 | Abdominal distention (HP:0003270) | 2.95699982 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.95124462 |
| 34 | Chronic diarrhea (HP:0002028) | 2.92705993 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 2.81497957 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.75016177 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 2.73591934 |
| 38 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.73591934 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 2.66097342 |
| 40 | Orchitis (HP:0100796) | 2.64947627 |
| 41 | Reticulocytosis (HP:0001923) | 2.64769648 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.63728888 |
| 43 | Nephrolithiasis (HP:0000787) | 2.60874747 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.57949840 |
| 45 | Increased mean platelet volume (HP:0011877) | 2.55215330 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.55210378 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53883291 |
| 48 | Myositis (HP:0100614) | 2.53541657 |
| 49 | Gingivitis (HP:0000230) | 2.52204045 |
| 50 | Increased IgE level (HP:0003212) | 2.49140548 |
| 51 | Amyloidosis (HP:0011034) | 2.48083030 |
| 52 | Skin nodule (HP:0200036) | 2.42179480 |
| 53 | Polycythemia (HP:0001901) | 2.32220517 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.31993958 |
| 55 | Gastrointestinal dysmotility (HP:0002579) | 2.31189270 |
| 56 | Mesangial abnormality (HP:0001966) | 2.29790456 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.28370274 |
| 58 | Peritonitis (HP:0002586) | 2.27635489 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.27550317 |
| 60 | Glycosuria (HP:0003076) | 2.27550317 |
| 61 | Petechiae (HP:0000967) | 2.26471827 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.26352638 |
| 63 | Protrusio acetabuli (HP:0003179) | 2.25072918 |
| 64 | Abnormal glucose tolerance (HP:0001952) | 2.24638171 |
| 65 | Myocardial infarction (HP:0001658) | 2.23781442 |
| 66 | Nausea (HP:0002018) | 2.23463237 |
| 67 | Dehydration (HP:0001944) | 2.23059422 |
| 68 | Premature rupture of membranes (HP:0001788) | 2.22513567 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.20842776 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20486269 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.20486269 |
| 72 | Pustule (HP:0200039) | 2.20103195 |
| 73 | Axonal loss (HP:0003447) | 2.19391065 |
| 74 | Hyperammonemia (HP:0001987) | 2.18246525 |
| 75 | Peripheral demyelination (HP:0011096) | 2.17708330 |
| 76 | Hyperparathyroidism (HP:0000843) | 2.17467856 |
| 77 | Esophageal varix (HP:0002040) | 2.17449916 |
| 78 | Alopecia of scalp (HP:0002293) | 2.16108101 |
| 79 | Spontaneous hematomas (HP:0007420) | 2.13935714 |
| 80 | Bone pain (HP:0002653) | 2.12525110 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.09485147 |
| 82 | Purpura (HP:0000979) | 2.07611677 |
| 83 | Deep venous thrombosis (HP:0002625) | 2.05477814 |
| 84 | Flat acetabular roof (HP:0003180) | 2.04932514 |
| 85 | Metaphyseal irregularity (HP:0003025) | 2.04763183 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04644400 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04644400 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04644400 |
| 89 | Abnormal platelet function (HP:0011869) | 2.03892567 |
| 90 | Impaired platelet aggregation (HP:0003540) | 2.03892567 |
| 91 | Nephritis (HP:0000123) | 2.01981542 |
| 92 | Metabolic acidosis (HP:0001942) | 2.01440962 |
| 93 | Hypophosphatemia (HP:0002148) | 2.00163396 |
| 94 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99529479 |
| 95 | Complement deficiency (HP:0004431) | 1.98534141 |
| 96 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.98323984 |
| 97 | Hematochezia (HP:0002573) | 1.97936937 |
| 98 | Abnormality of the costochondral junction (HP:0000919) | 1.95907750 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95883730 |
| 100 | Obstructive lung disease (HP:0006536) | 1.95883730 |
| 101 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95370653 |
| 102 | Retrobulbar optic neuritis (HP:0100654) | 1.95146440 |
| 103 | Optic neuritis (HP:0100653) | 1.95146440 |
| 104 | Abnormality of vitamin metabolism (HP:0100508) | 1.94438767 |
| 105 | Cervical subluxation (HP:0003308) | 1.91398070 |
| 106 | Emphysema (HP:0002097) | 1.90792864 |
| 107 | Steatorrhea (HP:0002570) | 1.90589120 |
| 108 | Vasculitis (HP:0002633) | 1.90347180 |
| 109 | Pulmonary infiltrates (HP:0002113) | 1.90136661 |
| 110 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90055658 |
| 111 | Confusion (HP:0001289) | 1.89200013 |
| 112 | Pancreatitis (HP:0001733) | 1.88263642 |
| 113 | Abnormality of vitamin B metabolism (HP:0004340) | 1.88214002 |
| 114 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88086941 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87203273 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.87129079 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 1.86950439 |
| 118 | Gastrointestinal infarctions (HP:0005244) | 1.86222431 |
| 119 | Wide cranial sutures (HP:0010537) | 1.85518864 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85274989 |
| 121 | Hyperbilirubinemia (HP:0002904) | 1.84683547 |
| 122 | Protuberant abdomen (HP:0001538) | 1.84609195 |
| 123 | Eczematoid dermatitis (HP:0000976) | 1.84606243 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84066052 |
| 125 | Dysostosis multiplex (HP:0000943) | 1.83125775 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.82744769 |
| 127 | Hemoptysis (HP:0002105) | 1.82337161 |
| 128 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80998340 |
| 129 | Villous atrophy (HP:0011473) | 1.80649769 |
| 130 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80649769 |
| 131 | Mediastinal lymphadenopathy (HP:0100721) | 1.79708883 |
| 132 | Glomerulonephritis (HP:0000099) | 1.79574464 |
| 133 | Increased serum ferritin (HP:0003281) | 1.79297357 |
| 134 | Disinhibition (HP:0000734) | 1.78738952 |
| 135 | Neurofibrillary tangles (HP:0002185) | 1.78574283 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77841308 |
| 137 | Enlarged epiphyses (HP:0010580) | 1.77500828 |
| 138 | Abnormality of the nasal mucosa (HP:0000433) | 1.75982034 |
| 139 | Loss of speech (HP:0002371) | 1.75268408 |
| 140 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74970866 |
| 141 | Thin bony cortex (HP:0002753) | 1.72770526 |
| 142 | Gingival bleeding (HP:0000225) | 1.71911121 |
| 143 | Hypoglycemic coma (HP:0001325) | 1.70667395 |
| 144 | Premature loss of primary teeth (HP:0006323) | 1.70236723 |
| 145 | Cheilitis (HP:0100825) | 1.67676874 |
| 146 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.67021376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.68586776 |
| 2 | MST4 | 4.61480006 |
| 3 | ERN1 | 4.24618295 |
| 4 | ACVR1B | 3.56630582 |
| 5 | GRK6 | 3.48311844 |
| 6 | MST1R | 3.45445710 |
| 7 | AKT3 | 2.97412458 |
| 8 | RIPK1 | 2.86815268 |
| 9 | PRKG2 | 2.47250177 |
| 10 | PTK6 | 2.46110797 |
| 11 | LMTK2 | 2.46057469 |
| 12 | MAP3K10 | 2.43949236 |
| 13 | PRPF4B | 2.32960654 |
| 14 | EPHA2 | 2.16654150 |
| 15 | NME1 | 1.96464463 |
| 16 | MAP3K2 | 1.86541271 |
| 17 | TBK1 | 1.75287072 |
| 18 | STK10 | 1.74032782 |
| 19 | CDC42BPA | 1.73886286 |
| 20 | MAP2K2 | 1.72762644 |
| 21 | EPHB1 | 1.68632493 |
| 22 | TAOK3 | 1.68424793 |
| 23 | TAOK2 | 1.53486438 |
| 24 | RIPK4 | 1.52421421 |
| 25 | TYK2 | 1.51483135 |
| 26 | BMX | 1.48077459 |
| 27 | MATK | 1.38788327 |
| 28 | IRAK3 | 1.37917620 |
| 29 | NUAK1 | 1.33347636 |
| 30 | MET | 1.24832072 |
| 31 | LATS1 | 1.23469264 |
| 32 | EPHB2 | 1.22347414 |
| 33 | CDK12 | 1.22014470 |
| 34 | FGFR4 | 1.21776806 |
| 35 | TAOK1 | 1.18639160 |
| 36 | SIK1 | 1.16434463 |
| 37 | TRIB3 | 1.14669525 |
| 38 | TESK2 | 1.11031614 |
| 39 | NME2 | 1.10991557 |
| 40 | PTK2 | 1.03216460 |
| 41 | GRK7 | 1.01858240 |
| 42 | PAK4 | 0.96705651 |
| 43 | KIT | 0.92881127 |
| 44 | TESK1 | 0.92023908 |
| 45 | KSR2 | 0.91590575 |
| 46 | ERBB2 | 0.91430021 |
| 47 | MAP3K3 | 0.91333191 |
| 48 | MAP3K11 | 0.89762139 |
| 49 | LRRK2 | 0.88095277 |
| 50 | CSK | 0.87805555 |
| 51 | DDR2 | 0.87798791 |
| 52 | MAP3K7 | 0.83570933 |
| 53 | MAP4K1 | 0.82895228 |
| 54 | PKN2 | 0.82545423 |
| 55 | BLK | 0.79884606 |
| 56 | SCYL2 | 0.79689969 |
| 57 | MAP3K13 | 0.76836428 |
| 58 | PRKAA2 | 0.76526044 |
| 59 | MAP3K8 | 0.76086973 |
| 60 | SMG1 | 0.75886017 |
| 61 | IKBKE | 0.75855128 |
| 62 | PRKD2 | 0.74874238 |
| 63 | IKBKB | 0.74620472 |
| 64 | CAMK1D | 0.73860020 |
| 65 | FER | 0.73338862 |
| 66 | MAP3K1 | 0.73054069 |
| 67 | JAK1 | 0.72098442 |
| 68 | MOS | 0.69543961 |
| 69 | IRAK1 | 0.66418141 |
| 70 | MAP3K14 | 0.66271882 |
| 71 | JAK2 | 0.65663085 |
| 72 | SYK | 0.64021611 |
| 73 | PRKCI | 0.62603389 |
| 74 | MAPK11 | 0.62456965 |
| 75 | PBK | 0.61508548 |
| 76 | LYN | 0.61114388 |
| 77 | CDK6 | 0.57914376 |
| 78 | STK3 | 0.57478097 |
| 79 | FGFR3 | 0.56837067 |
| 80 | RPS6KA2 | 0.56644646 |
| 81 | HCK | 0.56623190 |
| 82 | MAP2K1 | 0.54043862 |
| 83 | PDPK1 | 0.54004919 |
| 84 | TGFBR2 | 0.53524636 |
| 85 | BTK | 0.52976477 |
| 86 | EPHA3 | 0.52942376 |
| 87 | MAPK7 | 0.52554401 |
| 88 | ICK | 0.51993939 |
| 89 | LCK | 0.51950864 |
| 90 | PDK2 | 0.51010932 |
| 91 | BMPR2 | 0.49614149 |
| 92 | MAP3K6 | 0.48736185 |
| 93 | MAP3K5 | 0.47567059 |
| 94 | FGR | 0.47346201 |
| 95 | CSF1R | 0.47201994 |
| 96 | MAP2K6 | 0.46271505 |
| 97 | DYRK1B | 0.45946786 |
| 98 | ERBB4 | 0.45016302 |
| 99 | RPS6KL1 | 0.43985482 |
| 100 | RPS6KC1 | 0.43985482 |
| 101 | JAK3 | 0.42045239 |
| 102 | TTN | 0.41735445 |
| 103 | PDGFRA | 0.40952055 |
| 104 | CHUK | 0.40472687 |
| 105 | PRKCD | 0.40206971 |
| 106 | PIK3CA | 0.40168016 |
| 107 | FES | 0.39951144 |
| 108 | MAP2K3 | 0.39730790 |
| 109 | EGFR | 0.39079669 |
| 110 | GSK3A | 0.38285549 |
| 111 | SRC | 0.37990589 |
| 112 | CAMKK2 | 0.37846317 |
| 113 | IRAK2 | 0.36616264 |
| 114 | MAPKAPK2 | 0.36602633 |
| 115 | PIM2 | 0.35707607 |
| 116 | ITK | 0.35434724 |
| 117 | SIK3 | 0.35175327 |
| 118 | INSRR | 0.33834843 |
| 119 | FYN | 0.32055704 |
| 120 | PDGFRB | 0.31660884 |
| 121 | ZAP70 | 0.31489614 |
| 122 | PRKAA1 | 0.31017586 |
| 123 | PDK1 | 0.30574459 |
| 124 | MYLK | 0.30242974 |
| 125 | BCKDK | 0.29590362 |
| 126 | PRKACG | 0.29571104 |
| 127 | IRAK4 | 0.28954900 |
| 128 | ABL2 | 0.28551316 |
| 129 | SGK3 | 0.28010353 |
| 130 | ABL1 | 0.27863461 |
| 131 | NEK9 | 0.27666175 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.30755020 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.44052129 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.64054111 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.55155134 |
| 5 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 3.37001040 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 3.20915123 |
| 7 | Galactose metabolism_Homo sapiens_hsa00052 | 2.74550963 |
| 8 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.72373830 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.51003883 |
| 10 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.21947233 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18250197 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.11466416 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04023764 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80562775 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80247774 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78975741 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.76722959 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71246705 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.55369476 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.54706212 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52204306 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51146879 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.48953618 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.44432013 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44186772 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34155671 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33441126 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30270583 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.25226265 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24086416 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22347212 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.17755930 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12423569 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09146230 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06256240 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.02773965 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00754282 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99583973 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97836477 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96156130 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95884107 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95494077 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90949990 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.90139098 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88680737 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87829092 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87491950 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85745590 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83706843 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 0.81085539 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78798433 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.78218815 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.76807899 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76253001 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.76239792 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.75367493 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75296671 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75147229 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75124550 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72395185 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71826900 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70573602 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69091414 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68668453 |
| 65 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67122983 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66141860 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65008422 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63122925 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.61841759 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61686018 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60926507 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60634093 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57806589 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57513232 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.57103991 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56000700 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53906106 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53182059 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51661794 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51229220 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50049886 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.47101859 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.46936826 |
| 84 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.46805152 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45237856 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45223856 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45127080 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45046412 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44827220 |
| 90 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44395765 |
| 91 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43850730 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42670673 |
| 93 | Hepatitis C_Homo sapiens_hsa05160 | 0.42093387 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41998850 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40879641 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.40656520 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38287305 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37721342 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37323650 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36990435 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.36637695 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.36564984 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35935388 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.35561350 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.34576168 |
| 106 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33113761 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32911843 |
| 108 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32831711 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30605406 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30318632 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29374722 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29017726 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.27314640 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26651290 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25755488 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.23280054 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.23161698 |
| 118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22903979 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.21886240 |
| 120 | Adherens junction_Homo sapiens_hsa04520 | 0.21536386 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21278874 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21238792 |
| 123 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.19568135 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19482611 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19148027 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19095049 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.17548835 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.17168978 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17151899 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.15651793 |

